Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. The efficacy and safety of angio-seal percutaneous femoral artery closure device after diagnostic and therapeutic cardiac catheterizations - A single center's experience
 
  • Details
Options

The efficacy and safety of angio-seal percutaneous femoral artery closure device after diagnostic and therapeutic cardiac catheterizations - A single center's experience

Journal
Acta Cardiologica Sinica
Date Issued
2007-12-01
Author(s)
TING-HSING CHAO  
URI
https://www.scopus.com/pages/publications/39149136240
https://scholars.csmu.edu.tw/handle/123456789/30612
Abstract
Objective: The purpose of this study was to evaluate the safety and efficacy of a hemostatic puncture closure device (Angio-Seal Vascular Closure Device) in patients undergoing diagnostic and therapeutic cardiac catheterizations. Methods: All consecutive patients (n = 102) who received a hemostatic puncture closure device from January 2007 to May 2007 in the National Cheng Kung University Hospital were enrolled in the study. Of these, 45 (44%) patients received therapeutic cardiac catheterizations. Multivariate logistic regression analyses were used to determine the predictors of vascular complications. Results: Of 102 patients, there were 68 (67%) males, and the mean age was 67 ± 11 years. All devices were deployed successfully, and device dysfunction occurred in only one patient (0.98%), in whom successful hemostasis was achieved later by manual and sandbag compression. There were 17 patients (16.7%) with small hematoma (≦ 6 cm in diameter) and three (2.9%) with large hematoma after the procedure. Compared with patients in the diagnostic group, patients in the therapeutic group had insignificantly higher complications of large hematoma (n = 3) (6.7% vs 0%, p = 0.08). However, no patients developed pseudoaneurysms, arteriovenous fistulae, and late bleeding in need of vascular repairs and blood transfusion until 7 to 14 days after discharge in both groups. Using multivariate logistic regression method, older age (≧ 75 years) was the only risk factor for developing large hematoma. Conclusion: Angio-Seal device offers a safe and effective hemostasis of the femoral artery in patients undergoing diagnostic and therapeutic cardiac catheterizations with acceptable morbidity rates.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback